BBLG FY 2016 Earnings — Bone Biologics Corporation Revenue & Financial Results | Market Cap Arena

BBLGBone Biologics Corporation

$2M

FY 2016 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$0

Gross Profit

-$700

Operating Income

-$20M

Net Income

-$26M

EPS (Diluted)

$-24840.00

Cash Flow

Operating Cash Flow

-$7M

Free Cash Flow

-$7M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$973,085

Total Liabilities

$10M

Stockholders' Equity

-$8M

Cash & Equivalents

$620,375

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$700	-$4,451	+84.3%
Operating Income	-$20M	-$12M	-70.2%
Net Income	-$26M	-$14M	-86.5%